Key result
Non-RCT study designs provide essential insights into health outcomes research beyond standard therapeutic efficacy.
Why the study?
The traditional hierarchical pyramid of evidence emphasizing RCTs is suitable for evaluating therapeutic efficacy, but it may be inappropriate for many health outcomes research questions.
Key points are not available for this paper at this time.
Design
Review and 2 case studies
Answers are grounded in this paper and cite their sources.
Prioritizes RCTs for cardiology decisions; confirms evidence pyramid for researchers and policy.
Health outcomes research applies a wide range of meth-ods to identify optimal approaches to determine optimal approaches to determine the effects of healthcare interven-tions and policies. Critical evaluation skills are necessary to navigate the evidence and identify studies that should influ-ence clinical decision making and policy. A hierarchical “pyramid of evidence ” that emphasizes randomized con-trolled clinical trials (RCTs) has been promulgated as the approach to judging study design and quality. Whereas this hierarchy may be suitable for the evaluation of efficacy, it may be inappropriate for many health outcomes research questions. This article examines the relevance of this con-struct to questions beyond those of therapeutic efficacy and discusses the essential role of study designs beyond RCTs. The strengths and weaknesses of study designs commonly encountered in the medical literature are reviewed. The article concludes with 2 case studies that apply the concepts re-viewed and illustrate the need to match the study design with the research question. Of note, the concepts of internal validity, external validity, confounding, and bias are central to the discussion of the strengths and weaknesses of study designs in the medical literature. Readers not familiar with these concepts should refer to the Appendix in the online-only Data Supplement for clarification.
No takes yet. Share an insight, caveat, or question.
Ho et al. (2008) reported a review. Study designs beyond randomized controlled trials are essential for answering health outcomes research questions beyond therapeutic efficacy, as illustrated by 2 case studies.
Synapse has enriched 10 related papers. Consider them for comparative context: